Othon Wiltz
Dr. Wiltz's clinical interests include inflammatory bowel disease with special focus on fistulizing Crohn’s disease and surgical management in patients on biologics; rectal cancer care within a multidisciplinary setting; robotic colon and rectal surgery; and the treatment of benign anorectal conditions in ambulatory settings.
Dr. Wiltz’s research interests include the correlation of the genetic footprints in Crohn’s patients with fistulizing disease, rectal cancer genetic profiles as related to response to neoadjuvant chemotherapy and chemoradiation therapy, the immune modulation of response of colon and rectal cancer to adjuvant therapy and studying the pre-habilitation of surgical patients with both benign and malignant diseases.
<p>Othon Wiltz, MD, FACS, FASCRS, is a colon and rectal surgeon and Assistant Professor, Surgery at Montefiore Einstein. His clinical interests include inflammatory bowel disease with special focus on fistulizing Crohn’s disease and surgical management in patients on biologics; rectal cancer care within a multidisciplinary setting; robotic colon and rectal surgery; and the treatment of benign anorectal conditions in ambulatory settings.</p><p>After receiving his Bachelor of Arts in natural sciences at Johns Hopkins in 1981, Dr. Wiltz attended the College of Physicians and Surgeons at Columbia University, earning his Doctor of Medicine in 1985. He then went on to simultaneously pursue his general surgery residency at Deaconess/Beth Israel Hospital and a two-year surgical oncology fellowship at the Dana Farber Cancer Institute in Boston, completing these in 1992. He completed his colon and rectal surgery fellowship in 1993 at the University of Minnesota. In 2009, he earned his Master of Bioethics from the University of Navarra.</p><p>Dr. Wiltz’s research interests include the correlation of the genetic footprints in Crohn’s patients with fistulizing disease, rectal cancer genetic profiles as related to response to neoadjuvant chemotherapy and chemoradiation therapy, the immune modulation of response of colon and rectal cancer to adjuvant therapy and studying the pre-habilitation of surgical patients with both benign and malignant diseases. His research has been published in many peer-reviewed journals and presented nationally and internationally.</p><p>Dr. Wiltz is board certified in general surgery and colon and rectal surgery. He is a member of several professional memberships including the American College of Surgeons, the American Society of Colon and Rectal Surgeons, the Society of Gastrointestinal and Endoscopic Surgeons and the American Medical Association.</p>
Aaron Zev Tokayer
<p>Dr. Tokayer received his B.A. in from Yeshiva College and his M.D. from Albert Einstein College of Medicine of Yeshiva University. He completed an internship and residency at the Bronx Municipal Hospital Center and GI and Hepatology fellowship at Johns Hopkins Medical Center. He received an MHS degree in Clinical Epidemiology from Johns Hopkins School of Public Health. Dr. Tokayer then joined the Montefiore GI Faculty in 1992. He has been involved in the spectrum of clinical patient care, endoscopic interventions and teaching in the GI fellowship program. His areas of interest include clinical practice, patient care and education, endoscopic procedures and interventions, functional GI and motility disorders. He is Director of the GI Motility Lab where studies such as Esophageal Manometry, Esophageal Acid Monitoring and Impedance Testing, Ano-rectal Manometry and Defecatory Testing, Hydrogen Breath Testing for Bacterial overgrowth and Carbohydrate Maldigestion , and studies of gastric and intestinal transit. He works closely with colleagues of the Department of Radiology and Nuclear Medicine as well as the Department of Surgery in diagnosing and treating GI motility disorders.</p>
Jonathan M. Schwartz
<p>Jonathan M. Schwartz is a board Certified Transplant Hepatologist. He is a graduate of Tel Aviv University, Sackler School of Medicine. He was an Internal Medicine Resident at Albert Einstein College of Medicine and a Fellow in Gastroenterology/Transplant Hepatology at the University of Washington in Seattle. He returned to New York in 2011 from Portland, Oregon where he served as an Associate Professor of Medicine at Oregon Health and Sciences University.</p>
<p>Dr. Schwartz has an interest in treating patients with acute and chronic liver diseases including those patients with advanced liver diseases who require liver transplantation.</p>
<p>He has a special interest in the multidisciplinary care of patients with liver tumors.</p>
<p><strong><br /></strong></p>
<ul>
<li>Estes JD, Stolpman D, Olyaei A, Ham JM, <strong>Schwartz JM</strong>, Orloff SL. High Prevalence of Potentially Hepatotoxic Herbal Supplement Use in Fulminant Hepatic Failure Patients. Arch Surg. 2003;138(8):852-8.</li>
<li><strong>Schwartz JM</strong>, Beymer C, Althaus SJ, Larson AM, Zaman A, Glickerman D, Kowdley KV. Cardiopulmonary Consequences of Transjugular Intrahepatic Portosystemic Shunts: Role of Increased Pulmonary Artery Pressure. J Clin Gastroenterol 2004;38(7):590-594.</li>
<li>Lim LL, Scarborough J, Thorne J, Graham E, Kempen J, Mackensen F, Nguyen Q D, Prabriputaloong T, Read R, Suhler EB, <strong>Schwartz JM</strong>, Smith JR. Uveitis in Patients with Autoimmune Hepatitis. Am J Ophthalmol. 2009;147(2):332-338.</li>
<li>O’Glasser AY, Scott DA, Corless CL, Zaman A, Sasaki A, Gopal DV, Rayhill SC, Orloff SL, Ham JM, Rabkin JM, Flora K, Davies CH, Broberg CS, and <strong>Schwartz JM.</strong>Hepatic and Cardiac Iron Overload Among Patients with End-Stage Liver Disease Referred for Liver Transplantation. Clinical Transplantation. Clin Transplant. 2010 Sep-Oct;24(5):643-51.</li>
<li>Kanwal F, Befeler A, Chari R, Marrero J, Kahn J, Afdhal N, Morgan T, Roberts L, Mohanty SR, <strong>Schwartz J</strong>, Van Thiel D, Hassanein TI, Li J, Zeringue A, DiBisceglie A. Rate of Potentially Curative Treatment in Patients with Hepatocellular Carcinoma. Aliment Pharmacol Ther. 2012 Aug;36(3):257-65.</li>
<li>Bichoupan K1, <strong>Schwartz JM,</strong> Martel-Laferriere V, Giannattasio ER, Marfo K, Odin JA, Liu LU, Schiano TD, Perumalswami P, Bansal M, Gaglio PJ, Kalia H,Dieterich DT, Branch AD, Reinus JF. Effect of Fibrosis on Adverse Events in Patients with Hepatitis C Treated with Telaprevir. Aliment Pharmacol Ther. 2014;39(2):209-16.</li>
<li><strong>Schwartz J</strong> and Carithers RL. Epidemiology and Etiologic Associations of Primary Hepatocellular Carcinoma. In Rose BD, editor. Up to date in Gastroenterology and Hepatology. Up to date, Inc. Wellesley, MA, Updated 2014.</li>
<li><strong>Schwartz JM </strong>and Carithers RL, Jr. Clinical features, diagnosis, and screening for primary hepatocellular carcinoma. Up to date in Gastroenterology and Hepatology. Up to date, Inc. Wellesley, MA, Updated 2014.</li>
<li>Curley SA, Stewart KE, <strong>Schwartz JM</strong>, Carthers RL, Jr. Nonsurgical therapies for localized hepatocellular carcinoma. Up to date, Inc. Wellesley, MA, Updated 2014.<strong> </strong></li>
<li><strong>Schwartz JM</strong>. Approach to the patient with a focal liver lesion. Up to date Inc Gastroenterology and Hepatology. Up to date, Inc. Wellesley, MA, Updated 2014.</li>
<li>Hartwell L and <strong>Schwartz JM. </strong>AsymptomaticLiver Chemistry Abnormalities. Journal of Clinical Outcomes Management. 2009; 16 (11): 525-34.</li>
<li>Urquhart J<strong>, Schwartz, JM.</strong> Hepatocellular Carcinoma Surveillance in a Western Population with Hepatitis B. Current Hepatitis Reports, 2011.</li>
<li><strong>Schwartz, JM </strong>and Reinus JF. Prevalence and Natural History of Alcoholic Liver Disease. Clinics in Liver Disease. 2012; 16 (4): 659-66.</li>
</ul>
<p> </p>
Moyses Niremberg
Rebecca Levine
<p>Rebecca A. Levine, MD, is a board-certified surgeon specializing in the treatment of benign and malignant colorectal disease, including colorectal cancer, inflammatory bowel disease, motility disorders and anorectal pathology.</p>
<p>Trained in both basic and clinical research, Dr. Levine brings to Montefiore an understanding of how translational research can advance the prevention, diagnosis and treatment of colorectal cancer, the third most common cause of cancer in the United State</p>
Ester Ilyayeva
Renee Huang
Dr. Huang's clinical focus is on the treatment of rectal and other cancers at Montefiore with her expertise in using laparoscopic techniques.
<span style="font-size:16px;-webkit-text-size-adjust:auto;caret-color:#4d4d4d;color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;background-color:#ffffff;">Dr. Huang has co-led numerous clinical research studies on the use of laparoscopic techniques.</span>
<p><em>Renee Huang, MD advances the treatment of rectal and other cancers at Montefiore with her expertise in using laparoscopic techniques.</em></p><p>Dr. Renee Huang's extensive experience and research in using laparoscopic surgical techniques to treat rectal cancer, inflammatory bowel disease, and other serious gastrointestinal conditions greatly expands the Montefiore's surgical team's ability to used advanced technologies to care for our patients.</p><p>Dr. Huang, who joins our team from Barnabas Health Medical Group, where she was an attending physician in their colon and rectal diseases practice, has led and co-led numerous clinical research studies on the use of laparoscopic techniques. She completed a colon and rectal surgery fellowship at Grant Medical Center in Columbus, Ohio, and a fellowship in minimally invasive colorectal surgery and advanced rectal cancer management at Lankenau Medical Center in Wynnewood, Pennsylvania. She is a graduate of University of Buffalo Medical Center, and she completed her general surgery residency training from Albany Medical College.</p>
Joseph D. Frager
<p>Dr. Frager specializes in disorders of the Colon and Upper GI Tract including: Colon Polyps, Diverticulitis, Peptic Ulcer Disease, Gastroesophageal Reflux and Gallstones.</p>
<p>Immunology of the GI Tract</p>
<p>Joseph Frager, MD, is an Attending Physician in Gastroenterology and Assistant Professor of Medicine at Montefiore Einstein. Dr. Frager specializes in the diagnosis and treatment of disorders of the colon and upper gastrointestinal tract including colon polyps, diverticulitis, peptic ulcer disease, gastroesophageal reflux and gallstones.</p><p>After earning his Doctor of Medicine from University of Pennsylvania School of Medicine in 1980, Dr. Frager came to Montefiore for his postgraduate training. He completed his internal medicine internship and residency in 1983, followed by his fellowship in gastroenterology in 1985.</p><p>Dr. Frager’s research focus is on the immunology of the gastrointestinal tract. He has shared his work through peer-reviewed journals and abstracts.</p><p>Dr. Frager is board certified in Internal Medicine by the American Board of Internal Medicine. He is a member of the American College of Gastroenterology, the American Gastroenterology Association and the New York Society for Gastrointestinal Endoscopy.</p>
Abier A. Abdelnaby
Dr. Abdelnaby's clinical focus is on care for patients with all disorders of the colon, rectum and anus.
Dr. Abdelnaby performs clinical research investigating various topics in colon and rectal surgery.
<p>Abier A. Abdelnaby, MD, is Director, Colon and Rectal Surgical Services and Associate Professor, Surgery at Montefiore Einstein. She is a fellowship-trained colon and rectal surgeon with a clinical focus on care for patients with all disorders of the colon, rectum and anus.</p><p>After earning her Bachelor of Arts at Cornell University in 1996, Dr. Abdelnaby pursued her Doctor of Medicine at Howard University College of Medicine, receiving her degree in 2001. She continued at Howard University Hospital for her postdoctoral training, starting with a year-long internship followed by a four-year general surgery residency, which she completed in 2006. She then attended the University of Southern California, completing a colon and rectal surgery fellowship in 2007.</p><p>Dr. Abdelnaby performs clinical research investigating various topics in colon and rectal surgery. Her original research has been published in several journals and poster presentations, and she has contributed to book chapters and abstracts. She has presented her work regionally, nationally and internationally. Dr. Abdelnaby introduced the “Same Day Colectomy” practice to Montefiore Einstein which has had a great impact on patients.</p><p>Dr. Abdelnaby is board certified by the American Board of Surgery and The American Board of Colon and Rectal Surgery. She is a member of many professional associations, including The American Society of Colon and Rectal Surgeons, The American College of Surgeons, The International Society of University Colon and Rectal Surgeons, The Physicians for Peace Society, The SAGES Society and the Pan African Association of Surgeons.</p>